(PharmaNewsWire.Com, January 04, 2017 ) Global bio-implant market is growing at a CAGR of 8% from 2015-2021. The market is driven by various factors which include global rise in adoption of bio-implants, increase in number of people suffering from disabilities. It is giving rise to higher number of amputation. Rising incidence and prevalence rate of CVD, CHD and other heart diseases is also driving the market growth. Additionally, with increasing adoption of prosthetic limbs across geographies and rise in awareness about ear implants, pacemakers and other bio-implants are creating huge scope for global bio-implant market. Market is segmented on the basis of materials which include material such as ceramics, metal, alloys, polymers and others. Global bio-implant market by material and its type are extensively adopted by major hospitals and clinics for bio-implants. Further the market is segmented on the basis of bio implants type which includes CVD implants, spinal implants, orthopedic and trauma, dental, ophthalmic and neurostimulators. Stents, cardiac implant, ear implant are expected to contribute highest among all the segments of global bio-implant market. With the advancement in technology and innovation due to research and development segments such as dental implants, orthopedic implants are expected to contribute better in next few years.
In terms of geographical segmentation, North America is expected to lead the revenue in this market due to higher adoption of bio-implants such as cochlear implant, prosthetic implants, stents and so on followed by Europe. Asia Pacific market is expected to have the highest market growth. It is driven by growing awareness, rise in number of local manufacturers providing cheaper implants, availability of raw materials such as ceramics, metal and alloys in abundance and growing R&D. Bio-implant market consists of some major companies which includes Medtronic Inc, Abbot laboratories, AAP implantate AG, Bausch & Lomb incorporated, Biomet Inc, Biotronik SE & Co. KG, Boston scientific corporation, Crook group Inc, CR Bard Inc, Toshiba Corporation and others.
Companies profiled include
1. Medtronic Inc 2. Abbot laboratories 3. AAP implantate AG 4. Bausch & Lomb incorporated 5. Biomet Inc 6. Biotronik SE & Co. KG 7. Boston scientific corporation 8. Crook group Inc 9. CR Bard Inc 10. Toshiba Corporation 11. GE healthcare 12. Edwards lifesciences corporation 13. Endo health solutions Inc 14. Johnson & Johnson 15. Philips corporation 16. Stryker corporation 17. Integral lifesciences holdings corporation 18. Integrated orbital implants 19. Lifenet health Inc 20. Mimedx group Inc 21. Orthofix international N.V. 22. Smith & nephew, PLC 23. Zimmer holdings 24. Wright medical group incorporated 25. WL Gore & associates Inc 26. Tornier N.V. 27. Thoratec corporation 28. St. Jude medical Inc 29. Sorin S.P.A. 30. Intuitive surgicals This Occams Research Report covers 1. Historical data 2. Revenue forecasts, growth rates and CAGR up to 2021 3. Industry Analysis 4. Competitive Analysis 5. Key geographic growth data
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
